Abstract
Functionally improved cell therapy has brought enormous benefits for patients suffering from serious illnesses. With the advances in biomedical science, numerous diseases are known for their correlation with post-translational modification of proteins, such as glycation, which leads to the formation of toxic Advanced Glycation End Products (AGEs). Themortality and morbidity rates of toxic AGE-induced diseases are continuously increasing globally